相关实验视频
Updated: Jul 15, 2025

08:45
Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
23.8K
一种多草药配方对P-乙诱导的实验动物模型的抗失眠效应
S Sheethal1, M Ratheesh2, Svenia P Jose1
1Department of Biochemistry, St. Thomas College, Palai, Kottayam, Kerala, 686574, India.
Neurochemical research
|September 28, 2023
概括
这项研究表明,多草药配方 (SLP) 通过改善睡眠模式和神经递质平衡,有效治疗大鼠的失眠. 此外,SLP还可以减少炎症和氧化压力,为睡眠障碍提供有前途的自然疗法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 综合医学是一个整体医学.
背景情况:
- 睡眠障碍,特别是慢性失眠,会对身体和精神健康产生负面影响.
- 目前对失眠的治疗选择具有局限性和重大副作用.
- 需要有效和安全的治疗失眠.
研究的目的:
- 为了研究一种多草药配方 (SLP) 的抗失眠作用.
- 在实验性失眠模型中评估SLP对睡眠模式,神经递质,神经,氧化应激和炎症的影响.
主要方法:
- 实验性失眠在使用p-甲氨酸 (PCPA) 的老鼠中被诱导.
- 通过分析睡眠模式,神经递质和受体表达,神经热素水平,氧化应激标志物和炎症性细胞因子,评估了SLP的治疗效果.
- 在老鼠中,SLP用于PCPA诱导的失眠.
主要成果:
- 施用SLP显著改善了诱导失眠的老鼠的睡眠行为.
- SLP有助于维持神经递质,激素和受体水平处于平衡状态.
- SLP增加了神经质蛋白水平,减少了促炎性细胞因子,增强了抗氧化活性,并防止了脂质过氧化.
结论:
- 多草药配方SLP在治疗失眠等睡眠障碍方面表现出显著的疗效.
- SLP通过调节关键的神经递质系统和减轻相关的氧化应激和炎症来起作用.
- SLP呈现出一种潜在的治疗不眠症的药物,具有有利的安全性.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
196
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
196
Management of Insomnia
274
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
274
Sedatives and Hypnotics: Overview
428
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
428
Insomnia
99
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
99
Anxiolytic Drugs: Benzodiazepines and Buspirone
851
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
851
CNS Depressants: Barbiturates and Benzodiazepines
303
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
303

